Fundraising FoxTech Coast Angels — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
Actuate Therapeutics is a clinical-stage biopharmaceutical company developing elraglusib, a small-molecule GSK-3β inhibitor designed to treat difficult-to-treat cancers including pancreatic, melanoma, lung, and pediatric cancers through intravenous injection and oral tablet formulations.
BiotechFort Worth, US
Daniel Schmitt(President & Chief Executive Officer)Paul Lytle(Executive Officer)inAndrew Mazar(Executive Officer)
BoardTodd Thomson(Director)inRoger Sawhney(Director)Jason Keyes(Director)
Co-investorsIllinois VenturesKairos Venture Investments, LlcBiosBios PartnersDEFTA Partners
Actuate provides AI-based video analytics that turn existing IP cameras and NVRs into a security detection system, offering real-time alerts for threats such as intruders, loitering, guns, and crowds.
AI & Machine LearningCloud ComputingCybersecurityGovTechSaaS
Sonny Tai(Co-Founder)inKen Francis(CEO)in
Co-investorsBling CapitalDorm RoomGray Line PartnersMetaPropMetaProp VenturesScribble Ventures+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.